West Bengal Chemical Industries Limited (WBCIL) proudly announces its achievement as the only MSME in India to receive the esteemed National Intellectual Property Award 2024 under the category “Top Indian MSME for Patent Filing, Grant & Commercialization.” The recognition was conferred by the Ministry of Commerce & Industry, Government of India, at Bharat Mandapam, New Delhi, in the presence of Hon’ble Minister Shri Piyush Goyal, Hon’ble Justice Pratibha M. Singh, and key dignitaries from India라이브 바카라 innovation and intellectual property ecosystem.
“Innovation is the key to India's march towards a Viksit Bharat,” remarked Union Minister of Commerce & Industry, Shri Piyush Goyal, during this prestigious National Intellectual Property (IP) Awards 2024 ceremony. Organized annually by the Department for Promotion of Industry and Internal Trade (DPIIT) and the Indian IP Office, these awards recognize and reward individuals, institutions, and enterprises making outstanding contributions to the creation, protection, and successful commercialization of intellectual property.
The awards play a pivotal role in strengthening India's IP ecosystem, fostering a culture of innovation and creativity, and encouraging effective IP portfolio management. By celebrating organizations that strategically leverage intellectual property for innovation, the National IP Awards continue to inspire excellence across diverse industries.
This award reflects WBCIL라이브 바카라 relentless commitment to scientific research, innovation, and intellectual property generation over its illustrious 60+ year journey. With 15 patents filed and 9 successfully granted across APIs, mineral formulations, and nutraceutical technologies, WBCIL has consistently delivered innovation-driven products with real-world impact.
WBCIL Achieves WHO-GMP Certification
In addition to the National IP Award, WBCIL has also recently obtained WHO-GMP certification for its manufacturing units, further elevating its credibility in global pharmaceutical markets. Under the WHO-GMP Certification Scheme, WBCIL has received the Certificate of Pharmaceutical Product (COPP) for the following APIs:
Ferric Ammonium Citrate B.P
Calcium Acetate USP
Calcium Citrate USP
Ferrous Bisglycinate (In-House Specification)
This certification ensures that WBCIL라이브 바카라 APIs meet stringent international quality and regulatory benchmarks, enabling their export to regulated markets worldwide.
Strengthening India's IP and Innovation Ecosystem
The National Intellectual Property Award 2024 is a testament to WBCIL라이브 바카라 efforts in bridging science with market-ready innovations. The company has successfully commercialized several patented formulations and continues to expand its portfolio, especially in liposomal APIs, nutraceuticals, and cosmeceuticals.
WBCIL라이브 바카라 Managing Director, Mr. Sunil Kumar Agarwal, remarked, “This recognition motivates us to keep pushing boundaries, ensuring that WBCIL not only leads in innovation but also delivers globally accepted, high-quality, and patient-centric healthcare solutions.”
This achievement positions WBCIL as a model for Indian MSMEs, demonstrating that intellectual property excellence, coupled with international quality certifications like WHO-GMP, is the pathway to global leadership in pharmaceuticals.
For more information, visit:
🔗
